Bellevue Life Sciences advances $300K loan to OSR Holdings at 3.96% annual interest

OSR Holdings, Inc.

Loan of $300,000 to OSR Holdings, target of proposed business combination, evidenced by promissory note.
Interest rate 3.96% per annum, compound semi-annually; principal and interest due October 25, 2025.
Funds to be used for working capital and other expenses of OSR Holdings.
Default provisions include failure to pay within 5 business days of maturity and bankruptcy events.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.